Vivimed Labs share news, announcements and annual reports
NSE: VIVIMEDLABBSE: 532660Pharmaceuticals & BiotechnologySmall Cap
Vivimed Labs Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 2005
Last close ₹5.53down ₹0.11 (1.95%)
Share price at the NSE close on 30 Oct 2026. Previous close ₹5.64.
30 Oct: open ₹5.62, high ₹5.64, low ₹5.53
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹46 Cr3,293rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 3,267
Vivimed Labs share news and announcements
642 announcements, routine notices left out, newest first. Page 6 of 13.
Feb 2020
14 Feb · Results
Jan 2020
30 Jan · Board meeting
28 Jan · Meeting
Dec 2019
6 Dec · Legal
Exchange has sought clarification from Vivimed Labs Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Statement of Cash Flow not submitted The response of the Company is awaited.
Nov 2019
15 Nov · Board meeting
14 Nov · Results
Oct 2019
Sep 2019
30 Sep · Meeting
7 Sep · Updates
Aug 2019
9 Aug · Results
Jul 2019
31 Jul · Board meeting
Jun 2019
12 Jun · Results
May 2019
31 May · Results
17 May · Board meeting
8 May · Business
Apr 2019
16 Apr · Disclosure
Feb 2019
14 Feb · Results
4 Feb · Board meeting
1 Feb · Legal
Exchange has sought clarification from Vivimed Labs Limited with respect to announcement dated 29-Jan-2019, regarding a press release dated January 29, 2019, titled "SALE OF 50% STAKE IN ITS 50:50 JV TO STRIDES".". On basis of above the Company is required to clarify following: 1. Additionally, in case of a slump sale, indicative disclosures provided for amalgamation/merger, shall be disclosed by the listed entity with respect to such slump sale.2. Whether the transaction would fall within related party transactions? If yes, whether the same is done at "arm's length";3. Brief details of buyers and whether any of the buyers belong to the promoter/ promoter group/group companies. If yes, details thereof.4. Consideration received from such sale/disposal;5. The expected date of completion of sale/disposal;6. Date on which the agreement for sale has been entered into;7. The amount and percentage of the turnover or revenue or income and net worth contributed by such unit or division of the listed entity during the last financial year;The response of the Company is awaited.
Jan 2019
24 Jan · Legal
The exchange asked on 23 Jan 2019
Dec 2018
Nov 2018
14 Nov · Results
Oct 2018
11 Oct · Meeting
5 Oct · Business
Sep 2018
27 Sep · Meeting
10 Sep · Meeting
Aug 2018
23 Aug · Board meeting
17 Aug · Legal
Exchange has sought clarification from Vivimed Labs Limited with respect to announcement dated 13-Aug-2018, regarding " Vivimed Labs Limited has informed the Exchange regarding Outcome of Board Meeting held on August 13, 2018.". On basis of above the Company is required to clarify following: 1. Date of appointment/cessation (as applicable) & term of appointment; 2. Reason for change viz. appointment, resignation, removal, death or otherwise; The response of the Company is awaited.13 Aug · Board meeting
13 Aug · Results
1 Aug · Board meeting
Jul 2018
Jun 2018